Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
1,349.00
+71.00 (5.56%)
At close: Jun 2, 2026
CBSE:PRO Balance Sheet
Financials in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 138.19 | 100.04 | 62.74 | 106.3 | 160.12 |
Short-Term Investments | - | 17.99 | - | 19 | 74.97 |
Cash & Short-Term Investments | 138.19 | 118.03 | 62.74 | 125.3 | 235.09 |
Cash Growth | 17.08% | 88.12% | -49.93% | -46.70% | 68.99% |
Accounts Receivable | 227.62 | 230.42 | 257.7 | 164.54 | 116.37 |
Other Receivables | 65.38 | 76.05 | 60.1 | 22.97 | 5.54 |
Receivables | 293 | 306.47 | 317.8 | 187.51 | 121.91 |
Inventory | 358.73 | 330.28 | 281.02 | 223.96 | 147.35 |
Other Current Assets | 2.89 | 6 | 2.24 | 2.45 | 0.95 |
Total Current Assets | 792.81 | 760.78 | 663.81 | 539.22 | 505.3 |
Property, Plant & Equipment | 395.26 | 378 | 310.73 | 212.68 | 100.7 |
Other Intangible Assets | 6.76 | 8.44 | 9.86 | 10.83 | 10.1 |
Long-Term Deferred Charges | 24.94 | 9.91 | 0 | 0 | 0 |
Other Long-Term Assets | 0.17 | 0.14 | 0.13 | 0.14 | 0.1 |
Total Assets | 1,220 | 1,157 | 984.53 | 762.87 | 616.2 |
Accounts Payable | 328.08 | 305.74 | 299.94 | 176.91 | 96.41 |
Accrued Expenses | 48.9 | 37.95 | 32.95 | 32.44 | 30.99 |
Short-Term Debt | - | 0.34 | 26.8 | 0.99 | - |
Other Current Liabilities | 18.9 | 10.5 | 22.59 | 14.35 | 25.96 |
Total Current Liabilities | 395.87 | 354.53 | 382.28 | 224.68 | 153.36 |
Long-Term Debt | 189.97 | 227.57 | 104.37 | 67.53 | 30 |
Other Long-Term Liabilities | 25.14 | 25.52 | 14 | 11.78 | 9.25 |
Total Liabilities | 610.98 | 607.63 | 500.66 | 304 | 192.61 |
Common Stock | 100 | 100 | 100 | 100 | 100 |
Retained Earnings | 434.08 | 374.17 | 319.01 | 302.11 | 266.83 |
Comprehensive Income & Other | 74.87 | 75.47 | 64.86 | 56.76 | 56.76 |
Shareholders' Equity | 608.95 | 549.64 | 483.87 | 458.87 | 423.59 |
Total Liabilities & Equity | 1,220 | 1,157 | 984.53 | 762.87 | 616.2 |
Total Debt | 189.97 | 227.91 | 131.18 | 68.52 | 30 |
Net Cash (Debt) | -51.78 | -109.88 | -68.44 | 56.78 | 205.09 |
Net Cash Growth | - | - | - | -72.31% | 47.43% |
Net Cash Per Share | -51.78 | -109.88 | -68.44 | 56.78 | 205.09 |
Filing Date Shares Outstanding | 1 | 1 | 1 | 1 | 1 |
Total Common Shares Outstanding | 1 | 1 | 1 | 1 | 1 |
Working Capital | 396.94 | 406.24 | 281.52 | 314.54 | 351.94 |
Book Value Per Share | 608.95 | 549.64 | 483.87 | 458.87 | 423.59 |
Tangible Book Value | 602.19 | 541.2 | 474.01 | 448.04 | 413.48 |
Tangible Book Value Per Share | 602.19 | 541.20 | 474.01 | 448.04 | 413.48 |
Land | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 |
Buildings | 273.11 | 165.95 | 162.09 | 152.89 | 144.07 |
Machinery | 377.71 | 347.37 | 312.24 | 275.15 | 249.5 |
Construction In Progress | 117.48 | 224.44 | 180.75 | 115.61 | 25.12 |